Global and Japan Equine Rabies Immunoglobulin (ERIG) Market Insights, Forecast to 2031

Report ID: 1024038 | Published Date: Sep 2024 | No. of Page: 135 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Equine Rabies Immunoglobulin (ERIG) Product Introduction
    1.2 Market by Type
        1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type
        1.2.2 1500IU
        1.2.3 1000IU
        1.2.4 400IU
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application
        1.3.2 Category II Exposure
        1.3.3 Category III Exposure
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size, Estimates and Forecasts
        2.1.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue 2016-2027
        2.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales 2016-2027
    2.2 Global Equine Rabies Immunoglobulin (ERIG), Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Equine Rabies Immunoglobulin (ERIG) Historical Market Size by Region (2016-2021)
        2.3.1 Global Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2022-2027)
        2.4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2022-2027)

3 Global Equine Rabies Immunoglobulin (ERIG) Competitor Landscape by Players
    3.1 Global Top Equine Rabies Immunoglobulin (ERIG) Manufacturers by Sales
        3.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturer (2016-2021)
        3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Equine Rabies Immunoglobulin (ERIG) Manufacturers by Revenue
        3.2.1 Key Equine Rabies Immunoglobulin (ERIG) Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2016-2021)
        3.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Equine Rabies Immunoglobulin (ERIG) Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Equine Rabies Immunoglobulin (ERIG) Revenue in 2020
        3.2.6 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Manufacturers
    3.4 Global Equine Rabies Immunoglobulin (ERIG) Manufacturing Base Distribution, Product Types
        3.4.1 Equine Rabies Immunoglobulin (ERIG) Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Type
        3.4.3 Date of International Manufacturers Enter into Equine Rabies Immunoglobulin (ERIG) Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Type (2016-2021)
        4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2016-2021)
        4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2016-2021)
        4.1.3 Equine Rabies Immunoglobulin (ERIG) Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Type (2022-2027)
        4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2022-2027)
        4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Type (2022-2027)
        4.2.3 Equine Rabies Immunoglobulin (ERIG) Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Application (2016-2021)
        5.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2016-2021)
        5.1.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2016-2021)
        5.1.3 Equine Rabies Immunoglobulin (ERIG) Price by Application (2016-2021)
    5.2 Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Application (2022-2027)
        5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2022-2027)
        5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Application (2022-2027)
        5.2.3 Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
    6.1 Japan Equine Rabies Immunoglobulin (ERIG) Market Size YoY Growth 2016-2027
        6.1.1 Japan Equine Rabies Immunoglobulin (ERIG) Sales YoY Growth 2016-2027
        6.1.2 Japan Equine Rabies Immunoglobulin (ERIG) Revenue YoY Growth 2016-2027
        6.1.3 Japan Equine Rabies Immunoglobulin (ERIG) Market Share in Global Market 2016-2027
    6.2 Japan Equine Rabies Immunoglobulin (ERIG) Market Size by Players (International and Local Players)
        6.2.1 Japan Top Equine Rabies Immunoglobulin (ERIG) Players by Sales (2016-2021)
        6.2.2 Japan Top Equine Rabies Immunoglobulin (ERIG) Players by Revenue (2016-2021)
    6.3 Japan Equine Rabies Immunoglobulin (ERIG) Historic Market Review by Type (2016-2021)
        6.3.1 Japan Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2016-2021)
        6.3.2 Japan Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2016-2021)
        6.3.3 Japan Equine Rabies Immunoglobulin (ERIG) Price by Type (2016-2021)
    6.4 Japan Equine Rabies Immunoglobulin (ERIG) Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 Japan Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2022-2027)
        6.4.2 Japan Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Type (2022-2027)
        6.4.3 Japan Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2022-2027)
    6.5 Japan Equine Rabies Immunoglobulin (ERIG) Historic Market Review by Application (2016-2021)
        6.5.1 Japan Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2016-2021)
        6.5.2 Japan Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2016-2021)
        6.5.3 Japan Equine Rabies Immunoglobulin (ERIG) Price by Application (2016-2021)
    6.6 Japan Equine Rabies Immunoglobulin (ERIG) Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 Japan Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2022-2027)
        6.6.2 Japan Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Application (2022-2027)
        6.6.3 Japan Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Equine Rabies Immunoglobulin (ERIG) Market Size YoY Growth 2016-2027
    7.2 North America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
        7.2.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021)
        7.2.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021)
        7.2.3 United States
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Region
        8.2.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2016-2021)
        8.2.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia

9 Europe
    9.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size YoY Growth 2016-2027
    9.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
        9.2.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021)
        9.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size YoY Growth 2016-2027
    10.2 Latin America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
        10.2.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021)
        10.2.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
        11.2.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 Serum China
        12.1.1 Serum China Corporation Information
        12.1.2 Serum China Description and Business Overview
        12.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Serum China Equine Rabies Immunoglobulin (ERIG) Products Offered
        12.1.5 Serum China Recent Development
    12.2 Lanzhou Institute of Biological Products
        12.2.1 Lanzhou Institute of Biological Products Corporation Information
        12.2.2 Lanzhou Institute of Biological Products Description and Business Overview
        12.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Products Offered
        12.2.5 Lanzhou Institute of Biological Products Recent Development
    12.3 Wuhan Institute of Biological Products
        12.3.1 Wuhan Institute of Biological Products Corporation Information
        12.3.2 Wuhan Institute of Biological Products Description and Business Overview
        12.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Products Offered
        12.3.5 Wuhan Institute of Biological Products Recent Development
    12.4 Premium Serums
        12.4.1 Premium Serums Corporation Information
        12.4.2 Premium Serums Description and Business Overview
        12.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Products Offered
        12.4.5 Premium Serums Recent Development
    12.5 Haffkine Bio-Pharmaceutical
        12.5.1 Haffkine Bio-Pharmaceutical Corporation Information
        12.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
        12.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Products Offered
        12.5.5 Haffkine Bio-Pharmaceutical Recent Development
    12.6 Bharat Serums
        12.6.1 Bharat Serums Corporation Information
        12.6.2 Bharat Serums Description and Business Overview
        12.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Products Offered
        12.6.5 Bharat Serums Recent Development
    12.11 Serum China
        12.11.1 Serum China Corporation Information
        12.11.2 Serum China Description and Business Overview
        12.11.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Serum China Equine Rabies Immunoglobulin (ERIG) Products Offered
        12.11.5 Serum China Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
    13.2 Equine Rabies Immunoglobulin (ERIG) Market Drivers
    13.3 Equine Rabies Immunoglobulin (ERIG) Market Challenges
    13.4 Equine Rabies Immunoglobulin (ERIG) Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Equine Rabies Immunoglobulin (ERIG) Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of 1500IU
    Table 3. Major Manufacturers of 1000IU
    Table 4. Major Manufacturers of 400IU
    Table 5. Major Manufacturers of Other
    Table 6. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 7. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 8. Global Equine Rabies Immunoglobulin (ERIG) Sales by Regions (2016-2021) & (K Units)
    Table 9. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Regions (2016-2021)
    Table 10. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Regions (2016-2021) & (US$ Million)
    Table 11. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2022-2027) & (K Units)
    Table 12. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Region (2022-2027)
    Table 13. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Region (2022-2027)
    Table 15. Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2016-2021) (K Units)
    Table 16. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers (2016-2021)
    Table 17. Ranking of Global Top Equine Rabies Immunoglobulin (ERIG) Manufacturers by Revenue (US$ Million) in 2020
    Table 18. Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 19. Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2016-2021)
    Table 20. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 21. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2020)
    Table 22. Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Price (2016-2021) (US$/Unit)
    Table 23. Equine Rabies Immunoglobulin (ERIG) Manufacturers Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Type
    Table 25. Date of International Manufacturers Enter into Equine Rabies Immunoglobulin (ERIG) Market
    Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 27. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2016-2021) (K Units)
    Table 28. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2016-2021)
    Table 29. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2016-2021) (US$ Million)
    Table 30. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2016-2021)
    Table 31. Equine Rabies Immunoglobulin (ERIG) Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2022-2027) & (K Units)
    Table 33. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Type (2022-2027)
    Table 34. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast V (2022-2027) & (US$ Million)
    Table 35. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Type (2022-2027)
    Table 36. Global Equine Rabies Immunoglobulin (ERIG) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 37. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2016-2021) (K Units)
    Table 38. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2016-2021)
    Table 39. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2016-2021) (US$ Million)
    Table 40. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2016-2021)
    Table 41. Equine Rabies Immunoglobulin (ERIG) Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 42. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2022-2027) & (K Units)
    Table 43. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Application (2022-2027)
    Table 44. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 45. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Application (2022-2027)
    Table 46. Global Equine Rabies Immunoglobulin (ERIG) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 47. Japan Equine Rabies Immunoglobulin (ERIG) Sales (K Units) of Key Companies (2016-2021)
    Table 48. Japan Equine Rabies Immunoglobulin (ERIG) Sales Share by Company (2016-2021)
    Table 49. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Company (2016-2021)
    Table 50. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Share by Company (2016-2021)
    Table 51. Japan Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Type (2016-2021)
    Table 52. Japan Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2016-2021)
    Table 53. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 54. Japan Equine Rabies Immunoglobulin (ERIG) Price (US$/Unit) by Type (2016-2021)
    Table 55. Japan Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Type (2022-2027)
    Table 56. Japan Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2022-2027)
    Table 57. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 58. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2022-2027)
    Table 59. Japan Equine Rabies Immunoglobulin (ERIG) Price (US$/Unit) by Type (2022-2027)
    Table 60. Japan Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Application (2016-2021)
    Table 61. Japan Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2016-2021)
    Table 62. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 63. Japan Equine Rabies Immunoglobulin (ERIG) Price (US$/Unit) by Application (2016-2021)
    Table 64. Japan Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Application (2022-2027)
    Table 65. Japan Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2022-2027)
    Table 66. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 67. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2022-2027)
    Table 68. Japan Equine Rabies Immunoglobulin (ERIG) Price (US$/Unit) by Application (2022-2027)
    Table 69. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021) & (K Units)
    Table 70. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2016-2021)
    Table 71. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021) & (US$ Million)
    Table 72. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2016-2021)
    Table 73. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2016-2021) & (K Units)
    Table 74. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2016-2021)
    Table 75. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2016-2021) & (US$ Million)
    Table 76. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2016-2021)
    Table 77. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021) & (K Units)
    Table 78. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2016-2021)
    Table 79. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021) & (US$ Million)
    Table 80. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2016-2021)
    Table 81. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021) & (K Units)
    Table 82. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2016-2021)
    Table 83. Latin Americaa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021) & (US$ Million)
    Table 84. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021) & (K Units)
    Table 86. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2016-2021)
    Table 87. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021) & (US$ Million)
    Table 88. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2016-2021)
    Table 89. Serum China Corporation Information
    Table 90. Serum China Description and Business Overview
    Table 91. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 92. Serum China Equine Rabies Immunoglobulin (ERIG) Product
    Table 93. Serum China Recent Development
    Table 94. Lanzhou Institute of Biological Products Corporation Information
    Table 95. Lanzhou Institute of Biological Products Description and Business Overview
    Table 96. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 97. Lanzhou Institute of Biological Products Product
    Table 98. Lanzhou Institute of Biological Products Recent Development
    Table 99. Wuhan Institute of Biological Products Corporation Information
    Table 100. Wuhan Institute of Biological Products Description and Business Overview
    Table 101. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 102. Wuhan Institute of Biological Products Product
    Table 103. Wuhan Institute of Biological Products Recent Development
    Table 104. Premium Serums Corporation Information
    Table 105. Premium Serums Description and Business Overview
    Table 106. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 107. Premium Serums Product
    Table 108. Premium Serums Recent Development
    Table 109. Haffkine Bio-Pharmaceutical Corporation Information
    Table 110. Haffkine Bio-Pharmaceutical Description and Business Overview
    Table 111. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 112. Haffkine Bio-Pharmaceutical Product
    Table 113. Haffkine Bio-Pharmaceutical Recent Development
    Table 114. Bharat Serums Corporation Information
    Table 115. Bharat Serums Description and Business Overview
    Table 116. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 117. Bharat Serums Product
    Table 118. Bharat Serums Recent Development
    Table 119. Equine Rabies Immunoglobulin (ERIG) Market Trends
    Table 120. Equine Rabies Immunoglobulin (ERIG) Market Drivers
    Table 121. Equine Rabies Immunoglobulin (ERIG) Market Challenges
    Table 122. Equine Rabies Immunoglobulin (ERIG) Market Restraints
    Table 123. Equine Rabies Immunoglobulin (ERIG) Customers List
    Table 124. Equine Rabies Immunoglobulin (ERIG) Distributors List
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Equine Rabies Immunoglobulin (ERIG) Product Picture
    Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type in 2020 & 2027
    Figure 3. 1500IU Product Picture
    Figure 4. 1000IU Product Picture
    Figure 5. 400IU Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application in 2020 & 2027
    Figure 8. Category II Exposure
    Figure 9. Category III Exposure
    Figure 10. Equine Rabies Immunoglobulin (ERIG) Report Years Considered
    Figure 11. Global Equine Rabies Immunoglobulin (ERIG) Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Market Size 2016-2027 (US$ Million)
    Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Sales 2016-2027 (K Units)
    Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Market Size Market Share by Region: 2021 Versus 2027
    Figure 15. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2016-2021)
    Figure 16. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2020
    Figure 17. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2016-2021)
    Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in 2020
    Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturer in 2020
    Figure 20. The Top 10 and 5 Players Market Share by Equine Rabies Immunoglobulin (ERIG) Revenue in 2020
    Figure 21. Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 22. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2016-2021)
    Figure 23. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type in 2020
    Figure 24. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2016-2021)
    Figure 25. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type in 2020
    Figure 26. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2016-2021)
    Figure 27. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application in 2020
    Figure 28. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2016-2021)
    Figure 29. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application in 2020
    Figure 30. Japan Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate 2016-2027 (K Units)
    Figure 31. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. Japan Equine Rabies Immunoglobulin (ERIG) Market Share in Global Market 2016-2027
    Figure 33. Japan 5 and 10 Largest Equine Rabies Immunoglobulin (ERIG) Players Market Share by Revenue in Equine Rabies Immunoglobulin (ERIG) in 2020
    Figure 34. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2016-2021)
    Figure 35. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate by Type in 2016 & 2020
    Figure 36. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2016-2021)
    Figure 37. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate by Application in 2016 & 2020
    Figure 38. North America Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 39. North America Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 40. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2020
    Figure 41. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2020
    Figure 42. United States Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 43. United States Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Canada Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 45. Canada Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Europe Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 47. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 48. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2020
    Figure 49. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2020
    Figure 50. Germany Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 51. Germany Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 52. France Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 53. France Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 54. U.K. Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 55. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 56. Italy Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 57. Italy Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. Russia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 59. Russia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 61. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 62. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2020
    Figure 63. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in 2020
    Figure 64. China Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 65. China Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 66. Japan Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 67. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 68. South Korea Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 69. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 70. India Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 71. India Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. Australia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 73. Australia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. China Taiwan Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 75. China Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. Indonesia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 77. Indonesia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Thailand Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 79. Thailand Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. Malaysia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 81. Malaysia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 83. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 84. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2020
    Figure 85. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2020
    Figure 86. Mexico Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 87. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 88. Brazil Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 89. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 90. Argentina Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 91. Argentina Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 92. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 93. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 94. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2020
    Figure 95. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2020
    Figure 96. Turkey Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 97. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 98. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 99. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 100. UAE Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 101. UAE Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 102. Equine Rabies Immunoglobulin (ERIG) Value Chain
    Figure 103. Channels of Distribution
    Figure 104. Distributors Profiles
    Figure 105. Bottom-up and Top-down Approaches for This Report
    Figure 106. Data Triangulation
    Figure 107. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Frequently Asked Questions
Equine Rabies Immunoglobulin (ERIG) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Equine Rabies Immunoglobulin (ERIG) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Equine Rabies Immunoglobulin (ERIG) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Human Thrombin

Human Thrombin market is segmented by region (country), players, by Type, and by Application. Pla ... Read More

Rabies Antiserum

Rabies Antiserum market is segmented by region (country), players, by Type, and by Application. P ... Read More